Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
61.66 USD | -0.08% | -4.88% | +11.82% |
May. 21 | Ani Pharmaceuticals Insider Sold Shares Worth $794,568, According to a Recent SEC Filing | MT |
May. 20 | ANI Pharmaceuticals Launches Kionex Suspension | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.82% | 1.2B | |
+37.74% | 723B | |
+34.69% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.19% | 244B | |
+10.04% | 208B | |
-4.01% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- Guggenheim Adjusts ANI Pharmaceuticals' Price Target to $77 From $70, Maintains Buy Rating